Vol. 13/No. 2 | Oncology Fellows

Overcoming Hurdles to Biosimilar Uptake

September 06, 2021

Sanjiv S. Agarwala, MD, explains that biologics have revolutionized the treatment of serious conditions, including cancer, over the past few decades, however, costs are a pressing issue for all providers and biologics are a major culprit.